Investor Resources Home

Webcast ImageWebcast - Replay
Heron Therapeutics Inc at 2017 Health Care Conference
05/16/17 at 2:20 p.m. PT
At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$14.20
Change (%)0.00 (0.00%)
Volume0
Data as of 05/22/17 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
05/16/17
Download Documentation Company Update (May)

Recent News

More >>
DateTitle 
05/10/17Heron Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate ProgressPrinter Friendly Version
05/09/17Heron Therapeutics to Present at the Bank of America Merrill Lynch 2017 Healthcare ConferencePrinter Friendly Version
04/24/17Heron Therapeutics Appoints Robert E. Hoffman as Chief Financial Officer and Senior Vice President, FinancePrinter Friendly Version
03/28/17Heron Therapeutics to Present at the 16th Annual Needham Healthcare ConferencePrinter Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.